OVA Conjugated Human Hemojuvelin (HJV)

Produktübersicht

• Artikelname: OVA Conjugated Human Hemojuvelin (HJV)
• Artikelnummer: BIM-RPU50875
• Hersteller Artikelnummer: RPU50875
• Alternativnummer: BIM-RPU50875-50UG,BIM-RPU50875-100UG,BIM-RPU50875-1MG
• Hersteller: Biomatik Corporation
• Kategorie: Proteine/Peptide
• Applikation: SDS-PAGE, WB
• Spezies Reaktivität: Human
• Konjugation: OVA
• Alternative Synonym: HFE2, HFE2A, HJV, JH, RGMC, hemochromatosis type 2(Juvenile), Haemojuvelin, RGM domain family member C

Produktbeschreibung

OVA Conjugated Human Hemojuvelin (HJV) is a purified Conjugated Small Molecules. Purity: >90% by SDS-PAGE. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Hemojuvelin (HJV). Target Synonyms: HFE2, HFE2A, HJV, JH, RGMC, hemochromatosis type 2(Juvenile), Haemojuvelin, RGM domain family member C. Accession Number: Q6ZVN8. Gene ID: 148738. Expression Region: Glu229~Phe247. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Produkteigenschaften

• Tag: N-Terminal His Tag
• NCBI: 148738
• Puffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
• Expression System: Protein Conjugation
• Reinheit: >90% by SDS-PAGE
• Formulierung: Freeze-dried powder
• Target-Kategorie: Hemojuvelin (HJV)